#pharmaceutical-ma

[ follow ]
#antitrust #legal-dispute #obesity-drugs #obesity-treatments #pfizer #metsera
Business
fromMedCity News
1 week ago

Pfizer Lawsuits Allege Novo Nordisk's Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal - MedCity News

Pfizer secured regulatory approval for its $4.9B Metsera acquisition, but competing Novo Nordisk bid and related lawsuits may determine if and when the transaction closes.
Business
fromIrish Independent
1 month ago

Pfizer makes $4.9bn bet on obesity drugs

Pfizer will acquire obesity startup Metsera for about $4.9bn, paying $47.50 per share plus up to $22.50 in milestone-based payments.
[ Load more ]